Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07358910 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Study acronym: RACSMEI
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 22, 2026 (before its estimated April 16, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure etiologies and transmission dynamics. This knowledge gap hinders the design of effective prevention and control strategies. RACSMEI will improve understanding across multiple pathogens using a multidisciplinary One Health approach. We will answer key questions on burden, ecology, transmission and population immune status to inform targeted and culturally appropriate interventions. The project combines a nationally representative One Health survey, social-science methods, and multiplex, diverse diagnostics to efficiently test for 57 priority pathogens, including zoonotic and vector-borne agents, vaccine-preventable and elimination-targeted diseases, enteric, respiratory, and environmentally transmitted pathogens and selected neglected tropical diseases and parasites relevant to Cambodia. Mathematical modelling will reconstruct and forecast transmission dynamics and assess the potential impact of future public-health strategies. By integrating intersectoral data and innovative methods, RACSMEI will generate actionable evidence for public-health authorities, support precision One Health interventions, and help reduce disease burden in affected communities. The project also aims to ensure the transferability of methods and insights to other countries facing similar challenges.
Trial Details
NCT Number NCT07358910
Lead Sponsor Institut Pasteur du Cambodge
Collaborators: Institut Pasteur, CDC - Ministry of Health of Cambodia, UMR ASTRE (CIRAD), Malaria Consortium, Ministry of Agriculture, Forestry and Fisheries Cambodia
Conditions
(from sponsor)
Dengue, Chikungunya, Zika Virus Infection, Japanese Encephalitis, West Nile Virus, Tick-borne Encephalitis (TBE), Severe Fever With Thrombocytopenia Syndrome, Nipah Virus Infection +50 more
Related terms Adenoviridae Infections, Arenaviridae Infections, Brucellosis, Bunyaviridae Infections, Caliciviridae Infections, Chickenpox, Chikungunya Fever, Chlamydia Infections, Communicable Diseases, Dengue, Elephantiasis, Filarial, Encephalitis, Japanese, Encephalitis, Tick-Borne, Enterovirus Infections, Epstein-Barr Virus Infections, Giardiasis, Hantavirus Infections, Henipavirus Infections, Hepatitis A, Hepatitis E, Leishmaniasis, Leptospirosis, Malaria, Measles, Melioidosis, Meningitis, Mumps, Mycoplasma Infections, Neglected Diseases, Parvoviridae Infections, Q Fever, Rift Valley Fever, Rotavirus Infections, Rubella, Schistosomiasis, Severe Fever with Thrombocytopenia Syndrome, Tetanus, Trichuriasis, Vaccine-Preventable Diseases, Vector Borne Diseases, Whooping Cough, Yellow Fever, Zika Virus Infection, Zoonoses
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov